MINNETONKA, Minn., Sept. 26, 2013 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Accelovance, an award-winning, full-service clinical research organization (CRO) focused in early phase Oncology, Vaccines and General Medicine development, has joined the iMedNet™ Partner Program. Designation as an iMedNet Partner will facilitate Accelovance's ability to offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms.
"MedNet is extremely pleased to partner with Accelovance, a recognized industry leader," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "Given their well-documented track record of continuously reducing study costs and timelines, their selection of iMedNet EDC to further improve study efficiency is a major testament to the tremendous benefits that iMedNet can deliver. We look forward to working side-by-side with this growing organization and meeting their eClinical needs for many years to come."
"The adoption of the iMedNet technology further expands the breadth of available solutions within our data management offering. We believe this is an attractive option for Sponsors having an early phase concentration and a desire to utilize a state of the art eClinical solution to enhance study efficiencies while maintaining budget discipline," noted Steve Trevisan, President and CEO of Accelovance.
|SOURCE MedNet Solutions|
Copyright©2012 PR Newswire.
All rights reserved